As part of its four-day, 16th annual Live Symposium of Complex Coronary, Valvular and Vascular Cases symposium, Mount Sinai Medical Center conducted a nurse/technologist conference June 11. Beth Oliver, RN, DNP, vice president of clinical operations for Mount Sinai Heart, and Antonietta Tolentino, RN, MSN, ANP-C, served as co-directors of the all-day program, which included speakers from nursing, medicine, pharmacy and invasive cardiac catheterization.
In addition to her director duties, Tolentino also contributed to the days events as a guest speaker. Her presentation, Have Stents Substantially Evolved Over Time? New Advances in Stent Technology, covered bioresorbable and bioabsorbable stent technology, both in use and currently undergoing clinical trial. One such trial in the U.S. is being conducted by Abbott of its Absorb drug-eluting bioresorbable vascular scaffold device, which works by opening a clogged vessel and restoring blood flow to the heart in the same manner as a drug-eluting metallic stent.
Unlike the metallic stent, Tolentino said, Absorb is made of a naturally disolvable material, which makes for a scaffold that is more flexible and conformable to the vessel.
Bioresorbable stents may be the fourth revolution in stenting, Tolentino told the audience. The device is in use in Europe and parts of Latin America and Asia.
Abby Schwartz, RN, BSN, MBA, director of nursing, business development, presented on the increasing prevalence of diabetes and the importance of training healthcare personnel in proper screening and referral. This is not an older persons disease, she said. It affects people from 35 to 55.
Schwartz discussed Mount Sinais care model, which bridges heart hospital and network physicians.
Mount Sinais model looks at diabetes as a cardiovascular disease, she said. This allows for a network-interpreted system of care which includes the heart hospital, the diabetes center, and cardiovascular alliances.
The model provides practitioners with the right resources to render optimal care, Schwartz said.
Twenty percent of Mount Sinai admissions have diabetes or are pre-diabetic, she said. Therefore, to prevent readmission, discharge planning criteria is very important.
Physicians and practitioners complete a form for referral that includes information such as diabetes baseline assessment, a visual inspection, lower extremity neuropathy screening, a cardiovascular screen and blood glucose levels.
Patients are also given a diabetes report card that they bring to every doctor visit and when they come to the Heart Hospital, Schwartz said. They are also given a template to follow at home that includes basic nutrition and exercise to help diminish the chance of readmission.
The event marked the 16th year that Mount Sinai has hosted the symposium, which featured live broadcasts of cardiac procedures and panel discussions on treating patients with complex cardiovascular disease. This years program included the use of hand-held devices that let the audience answer two questions posed by speakers after each session. A record number of more than 1,100 cardiac healthcare professionals from around the world attended the event.
Tracey Boyd is a regional reporter.